GlassScriptPhysician profile
Michelle C Shen
NPI 1154686640
$3,220.98
in general payments reported to CMS, 2019-2025
13 companies · $1,398 in 2025
The $1,398 reported for 2025 was more than what 75% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $35.32 · 2023: $911 · 2024: $876 · 2025: $1,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,185.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $701.63 | 2022-2025 | Perclot, Seprafilm, Floseal |
| Stryker Corporation | $684.18 | 2023-2025 | Spy-Phi System, Molli, Switchpoint Infinity, Isuite |
| Medtronic, INC. | $332.27 | 2023-2025 | Signia, Ligasure |
| Elucent Medical | $286.13 | 2025 | |
| Ethicon US, LLC | $266.27 | 2023-2025 | Vistaseal, Stratafix, Surgiflo Hemostatic Matrix |
| Davol INC. | $217.78 | 2023-2024 | Arista Ah Flexitip |
| Dilon Technologies, INC. | $180.68 | 2025 | Hemoblast Bellows |
| Hologic Sales and Service, LLC | $168.55 | 2025 | Magtrace |
| W. L. Gore & Associates, INC. | $167.50 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Abbvie INC. | $97.95 | 2023 | Alloderm |
| Abbott Laboratories | $93.25 | 2024 | Freestyle Libre 3 |
| Coopersurgical, INC. | $19.60 | 2025 | Onetrac Lx |
| Kerecis Limited | $5.19 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Shen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.